RGC
AGN

Roberts, Glore & Co’s Allergan plc AGN Stock Holding History

Roberts, Glore & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,478
Closed -$793K – 179
2020
Q1 		$793K Sell
4,478
-186
-4% -$35K 0.34% 73
2019
Q4 		$891K Buy
4,664
+2,470
+113% +$446K 0.34% 75
2019
Q3 		$369K Sell
2,194
-372
-14% -$60.6K 0.23% 96
2019
Q2 		$430K Sell
2,566
-690
-21% -$95.5K 0.26% 89
2019
Q1 		$477K Sell
3,256
-555
-15% -$80.5K 0.3% 83
2018
Q4 		$509K Sell
3,811
-403
-10% -$66.1K 0.36% 77
2018
Q3 		$803K Buy
4,214
+5
+0.1% +$919 0.46% 69
2018
Q2 		$702K Sell
4,209
-465
-10% -$74.7K 0.43% 74
2018
Q1 		$787K Buy
4,674
+104
+2% +$17.4K 0.49% 60
2017
Q4 		$748K Sell
4,570
-2,473
-35% -$444K 0.46% 67
2017
Q3 		$1.44M Sell
7,043
-60
-0.8% -$14K 0.93% 32
2017
Q2 		$1.73M Buy
7,103
+75
+1% +$17.6K 1.15% 25
2017
Q1 		$1.68M Sell
7,028
-180
-2% -$41.9K 1.16% 24
2016
Q4 		$1.51M Buy
7,208
+830
+13% +$172K 1.06% 29
2016
Q3 		$1.47M Buy
6,378
+1,246
+24% +$304K 1.06% 29
2016
Q2 		$1.19M Buy
+5,132
New +$1.18M 0.9% 34

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Roberts, Glore & Co's AGN Position: Q2 2020 in Review

Roberts, Glore & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,478 shares — an estimated $793K sold.

Roberts, Glore & Co first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $1.73M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Roberts, Glore & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Roberts, Glore & Co sold 4,478 Allergan plc shares in Q2 2020, an estimated $793K.
  • Roberts, Glore & Co first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • Roberts, Glore & Co's Allergan plc position peaked at $1.73M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Roberts, Glore & Co's 13F filing for Q2 2020, filed 13 Aug 2020.